Ligand Pharmaceuticals
LGNDInsider trades and stock quote 2024-2026
All insider trades at Ligand Pharmaceuticals
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 7/1/2026 | Sell | Reardon, Andrew | CLO & Secretary | $313.0 | $1,566,377 |
| 6/16/2026 | Sell | Sabba, Stephen L. | Director | $254.0 | $544,830 |
| 6/12/2026 | Sell | Haas, Jason | Director | $255.5 | $1,651,320 |
| 6/11/2026 | Sell | Aryeh, Jason | Director | $250.0 | $1,125,000 |
| 6/10/2026 | Sell | Lamattina, John L. | Director | $249.1 | $1,151,774 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)